Sino-Argi Leading Biosciences (603970) — Strategic Asset Allocation Index
Sino-Argi Leading Biosciences (603970) has a Strategic Asset Allocation Index of 4.6% as of June 2023. Strategic assets (PP&E of CN¥71.11 Million plus long-term investments of CN¥-) total CN¥71.11 Million, measured against net assets of CN¥1.53 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 603970 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Sino-Argi Leading Biosciences Strategic Asset Allocation Index (2012–2022)
This chart shows how Sino-Argi Leading Biosciences's Strategic Asset Allocation Index has evolved across 11 annual periods from 2012 to 2022. As of June 2023, the index stands at 4.6%, representing strategic assets of CN¥71.11 Million against net assets of CN¥1.53 Billion CNY. For live market cap and overall valuation, see 603970 stock market capitalisation.
Annual Strategic Asset Allocation Index for Sino-Argi Leading Biosciences (2012–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Sino-Argi Leading Biosciences from 2012 to 2022, covering 11 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Sino-Argi Leading Biosciences book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 4.1% | CN¥60.39 Million | CN¥60.39 Million | CN¥- | CN¥1.48 Billion | ▼ -1.7 pp |
| 2021 | 5.8% | CN¥73.77 Million | CN¥73.77 Million | CN¥- | CN¥1.28 Billion | ▲ +2.1 pp |
| 2020 | 3.7% | CN¥42.06 Million | CN¥42.06 Million | CN¥- | CN¥1.14 Billion | ▲ +0.3 pp |
| 2019 | 3.4% | CN¥35.34 Million | CN¥35.34 Million | CN¥- | CN¥1.04 Billion | ▼ -0.8 pp |
| 2018 | 4.2% | CN¥40.12 Million | CN¥40.12 Million | CN¥- | CN¥957.07 Million | ▼ -1.6 pp |
| 2017 | 5.8% | CN¥50.51 Million | CN¥50.51 Million | CN¥- | CN¥866.35 Million | ▼ -9.3 pp |
| 2016 | 15.1% | CN¥65.07 Million | CN¥65.07 Million | CN¥- | CN¥431.42 Million | ▲ +2.0 pp |
| 2015 | 13.1% | CN¥45.24 Million | CN¥45.24 Million | CN¥- | CN¥344.56 Million | ▲ +5.6 pp |
| 2014 | 7.6% | CN¥22.01 Million | CN¥22.01 Million | CN¥- | CN¥290.44 Million | ▼ -0.8 pp |
| 2013 | 8.3% | CN¥21.90 Million | CN¥21.90 Million | CN¥- | CN¥262.68 Million | ▼ 0.0 pp |
| 2012 | 8.3% | CN¥20.15 Million | CN¥20.15 Million | CN¥- | CN¥241.63 Million | — |